CAS 775351-65-0
:Imeglimin
Description:
Imeglimin is a novel oral antihyperglycemic agent primarily used in the management of type 2 diabetes mellitus. It belongs to a new class of medications known as "glimin," which function by enhancing insulin sensitivity and promoting insulin secretion in a glucose-dependent manner. Imeglimin operates through multiple mechanisms, including the modulation of mitochondrial function, which helps improve glucose metabolism and reduce hepatic glucose production. The substance is characterized by its unique chemical structure, which includes a combination of imino and acyclic components, contributing to its pharmacological properties. Imeglimin has shown promise in clinical studies for its efficacy in lowering blood glucose levels, with a favorable safety profile and minimal risk of hypoglycemia. Additionally, it may have beneficial effects on weight management, making it an attractive option for patients with type 2 diabetes. As research continues, Imeglimin's role in diabetes management may expand, potentially offering new therapeutic avenues for individuals struggling with this chronic condition.
Formula:C6H13N5
InChI:InChI=1S/C6H13N5/c1-4-8-5(7)10-6(9-4)11(2)3/h4H,1-3H3,(H3,7,8,9,10)/t4-/m1/s1
InChI key:InChIKey=GFICWFZTBXUVIG-SCSAIBSYSA-N
SMILES:N(C)(C)C=1N[C@H](C)N=C(N)N1
Synonyms:- 1,3,5-Triazine-2,4-diamine, 3,6-dihydro-N2,N2,6-trimethyl-, (6R)-
- 1,3,5-Triazine-2,4-diamine,1,6-dihydro-N,N,6-trimethyl-, (6R)- (9CI)
- 1,3,5-Triazine-2,4-diamine, 1,6-dihydro-N,N,6-trimethyl-, (6R)-
- Imeglimin
- R-(4-Imino-6-methyl-1,4,5,6-tetrahydro-[1,3,5]trazin-2-yl)dimethylamine
- R-(4-Imino-6-methyl-1,4,5,6-tetrahydro-[1,3,5]triazin-2-yl)dimethylamine
- Imeglimin
- EMD 387008
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
Imeglimin
CAS:Imeglimin: first oral antidiabetic in its class, targets liver, muscle, & pancreatic β-cells for type 2 diabetes.Formula:C6H13N5Purity:98.97%Color and Shape:SolidMolecular weight:155.2
